EASD: Novo’s Ozempic tops Victoza, J&J’s Invokana in double head-to-head win

BARCELONA—Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins. Ozempic topped both SGLT2 drug Invokana from Johnson & Johnson and Novo’s own GLP-1 drug Victoza in head-to-head phase 3 contests, the Danish drugmaker said Tuesday at the European Association… Read More »

Register Online MGH Conference on Women’s Mental Health – October 17, 2019

Over the last few years, we have  seen an increasing number of women with substance use disorders in our clinic.  We are very excited that Dr. Edwin Raffi from the Center for Women’s Mental Health will speaking about treating this vulnerable population at our upcoming one day course in Women’s Mental Health in Boston on… Read More »